3M Littmann CORE Digital Stethoscope and Eko Announce New Collaboration: Companies to Focus On Delivering Comprehensive Health care Solutions to Drive Better Patient Outcomes

3M Littmann CORE Digital Stethoscope and Eko Collaboration: As the world of healthcare and its dependence on auscultation continues to evolve, digital technology is being introduced to meet the advancing demands of the industry.

To meet these changing needs, 3M™ Littmann® Stethoscopes and Eko are announcing a new collaboration that will marry best-in-class 3M Littmann stethoscope technology with advanced Eko digital innovations.

The new 3M Littmann CORE Digital Stethoscope offers clinicians access to both analog and digital auscultation options and connects to Eko’s software and AI algorithms1 to help clinicians better interpret sounds and detect heart murmurs. Benefits to clinicians include:

  • Helps increase confidence in auscultation assessments
  • Amplification2 and active noise cancellation
  • Visualization of sound data during auscultation
  • Access to Eko’s AI and clinical decision support, helping providers to screen for heart murmurs during routine physical exams
  • Access to Eko’s telemedicine software, making these benefits available for both in-person and remote patient care

“Today, 3M Littmann Stethoscopes embarks upon a new era in our long history as a pioneer in auscultation innovation and quality by introducing our most advanced stethoscope yet,” said Kristi Barnett, Sr. Director, 3M Medical Devices. “The new 3M Littmann CORE Digital Stethoscope combines the superior acoustics of the Littmann Cardiology IV Stethoscope with Eko’s digital technology and software to aid and enhance a clinician’s auscultation assessments.”

The collaboration between 3M Littmann Stethoscopes and Eko brings together two innovative companies that are focused on delivering comprehensive health care solutions that drive better patient outcomes.

“This combination is a gamechanger – allowing a physician in rural America or a nurse treating patients in a non-office setting to have access to cutting-edge clinical decision support.”

In January of this year, Eko received FDA clearance for an algorithm that can detect the presence of suspected heart murmurs. The 3M Littmann CORE Digital Stethoscope can connect to Eko software, including its heart murmur AI1 and its telemedicine software, enabling enhanced in-person or remote patient care.

“For clinicians, listening is a gateway to making critical diagnoses. Being able to confidently assess heart and lung sounds helps ensure the best cardiac and pulmonary care possible,” said Connor Landgraf, co-founder and CEO, Eko. “Partnering with 3M Littmann Stethoscopes allows us to incorporate the power of our digital and machine learning technology alongside the stethoscope trusted by millions of clinicians worldwide, which can help impact patient outcomes and quality of care. Combining the 3M Littmann CORE Digital Stethoscope with the Eko platform of software and AI helps clinicians elevate cardiopulmonary care to a whole new level.”

 

 

Source3M

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”